Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo
Open Access
- 18 September 2008
- journal article
- research article
- Published by Springer Nature in Investigational New Drugs
- Vol. 27 (4) , 304-318
Abstract
Flexible heteroarotinoids (Flex-Hets) compounds regulate growth, differentiation and apoptosis in cancer cells. The hypothesis of this study was that the lead Flex-Het, SHetA2, inhibits angiogenesis by blocking cytokine release from cancer cells. SHetA2 altered secretion of thrombospondin-4 (TSP-4), vascular endothelial growth factor A (VEGF) and fibroblast growth factor (bFGF) proteins from normal and cancerous ovarian and renal cultures. Thymidine phosphorylase (TP) expression was inhibited in cancer, but not normal cultures. Endothelial tube formation was stimulated by conditioned media from cancer but not normal cultures, and SHetA2 reduced secretion of this angiogenic activity. SHetA2 directly inhibited endothelial cell tube formation and proliferation through G1 cell cycle arrest, but not apoptosis. Recombinant TP reversed SHetA2 anti-angiogenic activity. SHetA2 inhibition of in vivo angiogenesis was observed in Caki-1 renal cancer xenografts. In conclusion, SHetA2 inhibits angiogenesis through alteration of angiogenic factor secretion by cancer cells and through direct effects on endothelial cells.Keywords
This publication has 31 references indexed in Scilit:
- The effect of thrombospondin-1 on breast cancer metastasisBreast Cancer Research and Treatment, 2008
- Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domainThe International Journal of Biochemistry & Cell Biology, 2008
- Mitochondrial Thymidine Kinase and the Enzymatic Network Regulating Thymidine Triphosphate Pools in Cultured Human CellsJournal of Biological Chemistry, 2007
- Antiangiogenic therapy for ovarian cancerCurrent Opinion in Oncology, 2007
- Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondriaMolecular Cancer Therapeutics, 2007
- 2-Deoxy-d-ribose inhibits hypoxia-induced apoptosis by suppressing the phosphorylation of p38 MAPKBiochemical and Biophysical Research Communications, 2006
- Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonistsInvestigational New Drugs, 2005
- Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growthJournal of Cellular and Molecular Medicine, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Synthesis and Characterization of Heteroarotinoids Demonstrate Structure Specificity RelationshipsJournal of Medicinal Chemistry, 1998